These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34298861)

  • 1. MCPIP1/Regnase-1 Expression in Keratinocytes of Patients with Hidradenitis Suppurativa: Preliminary Results.
    Krajewski PK; Szukała W; Lichawska-Cieślar A; Matusiak Ł; Jura J; Szepietowski JC
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.
    Hessam S; Gambichler T; Skrygan M; Sand M; Rüddel I; Scholl L; Bechara FG
    Eur J Dermatol; 2018 Aug; 28(4):449-456. PubMed ID: 30325321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitinase-3-like Protein 1 (YKL-40) Is Expressed in Lesional Skin in Hidradenitis Suppurativa.
    Salomon J; Piotrowska A; Matusiak Ł; Dzięgiel P; Szepietowski JC
    In Vivo; 2019; 33(1):141-143. PubMed ID: 30587614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NOD2 signalling in hidradenitis suppurativa.
    Gambichler T; Hessam S; Skrygan M; Bakirtzi M; Kasakovski D; Bechara FG
    Clin Exp Dermatol; 2021 Dec; 46(8):1488-1494. PubMed ID: 34056759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa.
    Thomi R; Yerly D; Yawalkar N; Simon D; Schlapbach C; Hunger RE
    Br J Dermatol; 2017 Nov; 177(5):1358-1366. PubMed ID: 28301691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P2X7 Receptor Is Overexpressed in the Lesional Skin of Subjects Affected by Hidradenitis Suppurativa: A Preliminary Study.
    Manfredini M; Giuliani AL; Ruina G; Gafà R; Bosi C; Zoppas E; Di Virgilio F; Bettoli V
    Dermatology; 2021; 237(1):111-118. PubMed ID: 31454821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa.
    Batycka-Baran A; Baran W; Nowicka-Suszko D; Koziol-Gałczyńska M; Bieniek A; Matusiak Ł; Łaczmański Ł; Szepietowski JC
    Dermatology; 2021; 237(5):733-739. PubMed ID: 33202403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary alterations during the development of hidradenitis suppurativa.
    Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix remodelling and MMP expression/activation are associated with hidradenitis suppurativa skin inflammation.
    Sanchez J; Le Jan S; Muller C; François C; Renard Y; Durlach A; Bernard P; Reguiai Z; Antonicelli F
    Exp Dermatol; 2019 May; 28(5):593-600. PubMed ID: 30903721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocyte-specific ablation of Mcpip1 impairs skin integrity and promotes local and systemic inflammation.
    Konieczny P; Lichawska-Cieslar A; Kwiecinska P; Cichy J; Pietrzycka R; Szukala W; Declercq W; Devos M; Paziewska A; Rumienczyk I; Kulecka M; Mikula M; Fu M; Borowczyk J; Santamaria-Babí LF; Jura J
    J Mol Med (Berl); 2019 Dec; 97(12):1669-1684. PubMed ID: 31786670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratinocytes and immune cells in the epidermis are key drivers of inflammation in hidradenitis suppurativa providing a rationale for novel topical therapies.
    Schell SL; Cong Z; Sennett ML; Gettle SL; Longenecker AL; Goldberg SR; Kirby JS; Helm MF; Nelson AM
    Br J Dermatol; 2023 Feb; 188(3):407-419. PubMed ID: 36680309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
    Emelianov VU; Bechara FG; Gläser R; Langan EA; Taungjaruwinai WM; Schröder JM; Meyer KC; Paus R
    Br J Dermatol; 2012 May; 166(5):1023-34. PubMed ID: 22136668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of innate defense antimicrobial peptides in hidradenitis suppurativa.
    Hofmann SC; Saborowski V; Lange S; Kern WV; Bruckner-Tuderman L; Rieg S
    J Am Acad Dermatol; 2012 Jun; 66(6):966-74. PubMed ID: 21982063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apremilast for moderate hidradenitis suppurativa: no significant change in lesional skin inflammatory biomarkers.
    Vossen ARJV; van der Zee HH; Davelaar N; Mus AMC; van Doorn MBA; Prens EP
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):761-765. PubMed ID: 30451329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-36 in hidradenitis suppurativa: evidence for a distinctive proinflammatory role and a key factor in the development of an inflammatory loop.
    Hessam S; Sand M; Gambichler T; Skrygan M; Rüddel I; Bechara FG
    Br J Dermatol; 2018 Mar; 178(3):761-767. PubMed ID: 28975626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa.
    Sabat R; Šimaitė D; Gudjonsson JE; Brembach TC; Witte K; Krause T; Kokolakis G; Bartnik E; Nikolaou C; Rill N; Coulibaly B; Levin C; Herrmann M; Salinas G; Leeuw T; Volk HD; Ghoreschi K; Wolk K
    J Allergy Clin Immunol; 2023 Apr; 151(4):1015-1026. PubMed ID: 36481267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions.
    Hessam S; Sand M; Skrygan M; Bechara FG
    Arch Dermatol Res; 2017 Sep; 309(7):557-565. PubMed ID: 28634830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCPIP1/Regnase-1 Restricts IL-17A- and IL-17C-Dependent Skin Inflammation.
    Monin L; Gudjonsson JE; Childs EE; Amatya N; Xing X; Verma AH; Coleman BM; Garg AV; Killeen M; Mathers A; Ward NL; Gaffen SL
    J Immunol; 2017 Jan; 198(2):767-775. PubMed ID: 27920272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.